WallStreetZenWallStreetZen

NYSE: NVO
Novo Nordisk A S Earnings & Revenue

Open Broker Account

NVO past earnings growth

How has NVO's earnings growth performed historically?
Company
1.53%
Industry
32.34%
Market
52.12%
NVO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NVO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NVO's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NVO past revenue growth

How has NVO's revenue growth performed historically?
Company
6.26%
Industry
1,118.31%
Market
114.3%
NVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVO earnings and revenue history

Current Revenue
$22.1B
Current Earnings
$7.1B
Current Profit Margin
32.1%

NVO Return on Equity

Current Company
72.8%
Current Industry
3.9%
Current Market
25.7%
NVO's Return on Equity (72.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NVO announces earnings.

NVO Return on Assets

Current Company
25.8%
Current Industry
3.3%
NVO is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NVO Return on Capital Employed

Current Company
63.45%
Current Industry
9.5%
NVO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NVO$21.48B$10.39B$6.90B+4.68%+5.59%
REGN$14.23B$6.70B$5.69B+22.13%+37.25%
VRTX$8.35B$4.13B$3.19B+31.40%+64.03%
MRNA$23.00B$15.97B$14.06B+599.40%+302.42%
BNTX$21.62B$17.28B$11.99B+523.19%+348.54%

Novo Nordisk A S Earnings & Revenue FAQ

What were NVO's earnings last quarter?

Novo Nordisk A S (NYSE: NVO) reported Q2 2022 earnings per share (EPS) of $0.82, up 2.14% year over year. Total Novo Nordisk A S earnings for the quarter were $1.87 billion. In the same quarter last year, Novo Nordisk A S's earnings per share (EPS) was $0.84.

If you're new to stock investing, here's how to buy Novo Nordisk A S stock.

What was NVO's earnings growth in the past year?

As of Q4 2022, Novo Nordisk A S's earnings has grown 1.53% year over year. This is 30.81 percentage points lower than the US Biotechnology industry earnings growth rate of 32.34%. Novo Nordisk A S's earnings in the past year totalled $6.90 billion.

What was NVO's revenue last quarter?

Novo Nordisk A S (NYSE: NVO) reported Q2 2022 revenue of $5.80 billion up 9.63% year over year. In the same quarter last year, Novo Nordisk A S's revenue was $5.29 billion.

What was NVO's revenue growth in the past year?

As of Q4 2022, Novo Nordisk A S's revenue has grown 6.26% year over year. This is 1,112.06 percentage points lower than the US Biotechnology industry revenue growth rate of 1,118.31%. Novo Nordisk A S's revenue in the past year totalled $21.48 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.